These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29069749)

  • 1.
    Riedl S; Rinner B; Schaider H; Liegl-Atzwanger B; Meditz K; Preishuber-Pflügl J; Grissenberger S; Lohner K; Zweytick D
    Oncotarget; 2017 Sep; 8(42):71817-71832. PubMed ID: 29069749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.
    Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D
    Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
    Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
    PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
    Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
    Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
    Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli.
    Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B
    Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis.
    Wußmann M; Groeber-Becker FK; Riedl S; Alihodzic D; Padaric D; Gerlitz L; Stallinger A; Liegl-Atzwanger B; Zweytick D; Rinner B
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
    Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
    Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
    Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
    J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization.
    Heitzer E; Groenewoud A; Meditz K; Lohberger B; Liegl-Atzwanger B; Prokesch A; Kashofer K; Behrens D; Haybaeck J; Kolb-Lenz D; Koefeler H; Riedl S; Schaider H; Fischer C; Snaar-Jagalska BE; de'Jong D; Szuhai K; Zweytick D; Rinner B
    Sci Rep; 2019 Mar; 9(1):4096. PubMed ID: 30858407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo.
    Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG
    Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of benzyl-isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375.S2 cells.
    Ni WY; Hsiao YP; Hsu SC; Hsueh SC; Chang CH; Ji BC; Yang JS; Lu HF; Chung JG
    In Vivo; 2013; 27(5):623-6. PubMed ID: 23988897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity.
    Zweytick D; Pabst G; Abuja PM; Jilek A; Blondelle SE; Andrä J; Jerala R; Monreal D; Martinez de Tejada G; Lohner K
    Biochim Biophys Acta; 2006 Sep; 1758(9):1426-35. PubMed ID: 16616888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
    Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
    Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the Antimicrobial Activity of Two Lactoferricin Derivatives in
    Marx L; Semeraro EF; Mandl J; Kremser J; Frewein MP; Malanovic N; Lohner K; Pabst G
    Front Med Technol; 2021; 3():625975. PubMed ID: 35047906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing melanoma treatment with resveratrol.
    Osmond GW; Augustine CK; Zipfel PA; Padussis J; Tyler DS
    J Surg Res; 2012 Jan; 172(1):109-15. PubMed ID: 20855085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
    Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
    J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.
    Eliassen LT; Berge G; Leknessund A; Wikman M; Lindin I; Løkke C; Ponthan F; Johnsen JI; Sveinbjørnsson B; Kogner P; Flaegstad T; Rekdal Ø
    Int J Cancer; 2006 Aug; 119(3):493-500. PubMed ID: 16572423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.